Volume 6, Issue 2
Drug Evaluationp. 231
Mepolizumab in the treatment of eosinophilic esophagitis
Author(s): Rana F Ammoury and Sandeep K Gupta
Drug Evaluationp. 239
Capecitabine in colorectal cancer
Author(s): Michael S Braun and Chris J Twelves
Review Article
Motor side effects of atypical antipsychotic drugs
Author(s): Victoria Chang and Joseph H Friedman
Review Articlep. 259
Alzheimers disease: from pathogenesis to novel therapeutic approaches
Author(s): Elio Scarpini and Daniela Galimberti
Conference Proceedingp. 279
Briefings from ACAAI 2008 Annual meeting
Author(s): Desiree Larenas-Linnemann
Appendicesp. 286
Indices: Volume 6 Issue 2
Appendicesp. 284
Glossary: Volume 6 Issue 2
Appendicesp. 290
AUTHOR GUIDELINES: Volume 6 Issue 2
Appendicesp. 289
ACKNOWLEDGEMENTS: Volume 6 Issue 2
Forewordp. 131
Neurogenic bladder: current and future treatment strategies
Author(s): Jeffrey S Palmer
Editorialp. 133
Two popular treatment options for neurogenic bladder
Author(s): Raymond Bologna, Jeffrey S Palmer
News and Viewsp. 135
News & Views in Targeted anticancer therapy
Interviewp. 139
Current and future treatment of neurogenic bladder
Author(s): Howard B Goldman
Research Highlightsp. 143
Highlights from the latest articles in the treatment of neurogenic bladder
Author(s): Michael Ingber and Sandip Vasavada
Review Articlep. 145
Application and comparison of the AUA and EAU current recommendations for antibiotic prophylaxis in the urologic patient undergoing office procedures
Author(s): Morgan Koepke, Jeffrey Cerone and Raymond Bologna
Review Articlep. 151
Anatomy of urinary continence and neurogenic incontinence
Author(s): Jacob Golomb, Boris Chertin and Yoram Mor1
Review Articlep. 157
Surgical and nonsurgical treatment options for pediatric neurogenic bladder
Author(s): Boris Chertin, Jacob Golomb and Yoram Mor
Review Articlep. 165
Botulinum toxin: historical perspective and treatment of neurogenic and idiopathic overactive bladder
Author(s): Daniel Mulligan and Raymond Bologna
Review Articlep. 177
Regenerative medicine strategies for treatment of neurogenic bladder
Author(s): Roberto Soler, Claudius Fullhase and Anthony Atala
Editorialp. 187
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation
Author(s): Aurangzeb Siddique, Gregory YH Lip and Eduard Shantsila
Bulletin Boardp. 191
Bulletin Board: Volume-6, Issue-2
Drug Evaluationp. 199
Liraglutide: a human GLP-1 analog for Type 2 diabetes
Author(s): Tina Vilsboll
Drug Evaluationp. 209
Insulin glulisine: preclinical hallmarks and clinical efficacy
Author(s): Freimut Schliess and Tim Heise
